Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'delta' OR with Authors including 'delta' OR with Abstract including 'delta' OR with Keywords including 'delta'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Himwich HE, van Meter WG,... An EEG analysis of psychotomimetic drugs. Neuro-Psychopharmaco... 1959
Fink M EEG and behavioral effects of psychopharmacologic agents. Neuro-Psychopharmaco... 1959
Silva MTA, Carlini EA Lack of cross-tolerance in rats among (-)delta 9 -trans- tetrahydrocan... Psychopharmacologia 1968
Isbell H A comparison of LSD-25 with (-)-delta9-trans-tetrahydrocannabinol (THC... Psychopharmacologia 1969
Carlini EA, Masur J Development of fighting behavior in starved rats of chronic administra... Behav. Biol. 1970
Brown H Some anticholinergic-like behavioural effects of trans (-)delta8 tetra... Psychopharmacologia ... 1971
Domino EF, Bartolini A Effects of various psychotomimetic agents on the EEG and acetylcholine... Neuropharmacoloy 1972
Watanabe S, Nishi H, Ueki... Electroencephalographic effects of delta9-tetrahydrocannabinol, LSD-25... Jap. J. Pharmacol. 1972
Poddar MK, Ghosh JJ Effect of cannabis extract, delta 9 tetrahydrocannabinol and lysergic ... Biochem. Pharmacol. 1972
Yamada K, Ogawa N, Gomita... State-Dependent Learning (Dissociation of Learning) with Hallucinogens... Jap.Pharmacol. 1973
Kaymakcalan S Tolerance to and dependence on cannabis. Bull.Narcotics 1973
Burstein S, Levin E, Vara... Prostaglandins And Cannabis - II. Inhibition Of Biosynthesis By The Na... Biochem Pharm 1973
Miller LL, Drew WG, Wikle... Comparison of delta 9- THC, LSD-25 and scopolamine on non-spatial sing... Psychopharmacologia 1973
Drew WG, Miller LL, Baugh... Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneo... Psychopharmacologia 1973
Shaffer JH, Hill RM, Fisc... Psychophysics of Psilocybin and Delta-9-Tetrahydrocannabinol Agents and Actions 1973
Segelman AB, Sofia RD Cannabis sativa L. (Marijuana) IV: Chemical basis for increased potenc... J Pharm Sci 1973
Boyd ES, Boyd EH, Brown L... The Effects Of Some Drugs On An Evoked Response Sensitive To Tetrahydr... J Pharmacol.exp.Ther... 1974
Voight D, Johne S, Groege... Untersuchungen zur Massenspektrometrie von Mutterkornalkaloiden Pharmazie 1974
Ghosh JJ, et al A comparative study of delta-9-tetrahydro cannabinol and lysergic and ... J Pharmacol 1974
Widman M, Agurell S, Ehrn... Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-... J Pharm Pharmacol 1974
Fischer R, Goldman H Therapeutic Usefulness of Hallucinogenic Drugs as a Function of their ... Pharmakopsychiat 1975
Green JP Psychopharmacologic Activity: Quantum Chemical Study. Psychopharmacol Bull 1975
Masoud A N Systematic Identification of Drugs of Abuse I: Spot Tests J.Pharm.Sci. 1975
Silva MTA, Calil HM Screening Hallucinogenic Drugs: Systematic Study of Three Behavoral Te... Psychopharmacologia 1975
Biswas B, Ghos JJ Delta 9 Tetrahydrocannabinol And Lysergic Acid Diethylamide: Comparati... Anat. Anz. 1975
Henriksson BG, Johansson ... Delta 9 Tetrahydrocannabinol Produced Discrimination In Pigeons Pharm Biochem Behav 1975
Karasek FW, Karasek DE, K... Detection of Lysergic Acid Diethylamide, delta-9-Tetrahydro-Cannabinol... J.Chrornatog. 1975
Kaymakcalan S Detection Of Dependence Producing Drugs In Body Fluids Ankara Univ. Tip Fak... 1975
Mitra G, Poddar MK, Ghosh... Interaction of Cannabis Extract with Reserpine, Phenobarbital, Ampheta... Indian Journal of Bi... 1975
Smith SJ Effects Of Psychotropic Drugs On Brain Nuclear RNA Psychopharmacology B... 1975
Munson AE, Harris LS, Fri... Antineoplastic activity of cannabinoids J Natl Cancer Inst 1975
Schoenfeld RI Lysergic Acid Diethylamide and Mescaline-Induced Attenuation of the Ef... Science 1976
Waser PG, Martin A, Heer-... The Effect of delta-9-Tetrahydrocannabinol and LSD on the Acquisition ... Psychopharmacologia 1976
Fleisher LG Stimulus properties of Hallucinogens in the Rat and the Squirrel Monke... Dissertation Abstr.I... 1976
Jacobs BL, Trulson ME, St... An Animal Behavior Model for Studying the Actions of LSD and Related H... Science 1976
Martin P, Consroe P Cannabinoid Induced Behavioral Convulsions in Rabbits Science 1976
Masoud AN Systematic Identification of Drugs of Abuse II: TLC J.Pharm.Sci. 1976
Pickworth WB, Sharpe LG The Transcallosally Evoked Potential (TEP) Following Administration Of... Fed.Proc. 1976
Pryor GT, Husain S, Mitom... Acute and Subacute Interactions Between delta-9-Tetrahydrocannabinol a... Ann.N.Y.Acad.Sci. 1976
Szkelyhidi L, Szekelyhidi... Psychotomimetic agents Part II. Analytical aspects of psychotomimetics Gyógysserészet 1976
Wheals BB Forensic Applications of Liquid Chromatography Proc. Anal. Div. Che... 1976
Marshman JA, Popham RE, Y... A note on the cannabinoid content of Jamaican ganja Bull Narc 1976
Carlini EA Further Studies of the Aggressive Behavior Induced by delta-9-Tetrahyd... Psychopharmacology 1977
Mitra G, Poddar MK, Ghosh... Interaction of delta-9-Tetrahydrocannabinol with Reserpine, Phenobarbi... Toxicol.Appl.Pharmac... 1977
West LG, McLaughlin JL Triterpenes from the button cactus, Epithelantha micromeris Lloydia 1977
CaLil HM Screening Hallucinogenic Drugs. II. Systemic Study of Two Behavioral T... Psychopharmacology 1978
Frischknecht HR, Waser PG Actions of Hallucinogens on Ants (Formica Pratensis)-II. Effects of Am... Gen.Pharmacol. 1978
Kataoka Y, Shibata K, Fuj... Effects of psychotropic drugs on labor division between rats Japan. J. Pharmacol. 1978
Kay DC, Martin WR LSD and Tryptamine Effects on Sleep/Wakefulness and Electrocorticogram... Psychopharmacology 1978
Van Went GF Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and d 9-THC, ... Experientia 1978
Siegel RK Pharmacology of Hallucinogens: HALLUCINOGENS AND ATTENTIONAL DYSFUNCTI... The Psychopharmacolo... 1978
Frischknecht HR, Waser PG Actions of Hallucinogens on Ants (Formica Pratensis)-III. Social Behav... Gen.Pharmacol. 1980
Hunt CA, Jones RT Tolerance and disposition of tetrahydrocannabinol in man J Pharmacol Exp Ther 1980
Lindgren JE, Ohlsson A, A... Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (de... Psychopharmacology (... 1981
Vaupel DB, Morton EC Anorexia and Hyperphagia Produced by Five Pharmacologic Classes of Hal... Pharmacology, Bioche... 1982
Perez-Reyes M, Wall ME Presence of delta9-tetrahydrocannabinol in human milk N Engl J Med 1982
Weissman A, Milne GM, Mel... Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcycloh... J Pharmacol Exp Ther 1982
Wall ME, Sadler BM, Brine... Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol ... Clin Pharmacol Ther 1983
Battaglia G, Brooks BP, K... Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... Eur J Pharmacol 1988
Mechoulam R, Feigenbaum J... Enantiomeric cannabinoids: stereospecificity of psychotropic activity Experientia 1988
Fujimoto RA, Boxer J, Jac... Synthesis, opioid receptor binding profile, and antinociceptive activi... J Med Chem 1989
Dimpfel W, Spuler M, Nich... Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... Psychopharmacology (... 1989
Herkenham M, Lynn AB, Lit... Cannabinoid receptor localization in brain Proc Natl Acad Sci U... 1990
Astley SJ, Little RE Maternal marijuana use during lactation and infant development at one ... Neurotoxicol Teratol 1990
Reggio PH, McGaughey GB, ... A rational search for the separation of psychoactivity and analgesia i... Pharmacol Biochem Be... 1991
Narimatsu S, Watanabe K, ... Cytochrome P-450 isozymes involved in the oxidative metabolism of delt... Drug Metab Dispos 1992
Devane WA, Breuer A, Shes... A novel probe for the cannabinoid receptor J Med Chem 1992
Huestis MA, Henningfield ... Blood cannabinoidsIAbsorption of THC and formation of 11-OH-THC and TH... J Anal Toxicol 1992
Rudnick G, Wall SC Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serot... Mol Pharmacol 1993
Schuldiner S, Steiner-Mor... Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... Mol Pharmacol 1993
Sarnyai Z, Kovacs GL Role of oxytocin in the neuroadaptation to drugs of abuse Psychoneuroendocrino... 1994
Azorlosa JL, Greenwald MK... Marijuana smoking: effects of varying puff volume and breathhold durat... J Pharmacol Exp Ther 1995
Barrett RL, Wiley JL, Bal... Pharmacological specificity of delta 9-tetrahydrocannabinol discrimina... Psychopharmacology (... 1995
Reid LD, Hubbell CL, Tsai... Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... Pharmacol Biochem Be... 1995
Matsunaga T, Iwawaki Y, W... Metabolism of delta 9-tetrahydrocannabinol by cytochrome P450 isozymes... Life Sci 1995
Watanabe K, Matsunaga T, ... Involvement of CYP2C in the metabolism of cannabinoids by human hepati... Biol Pharm Bull 1995
Kintz P, Tracqui A, Mangi... Sweat testing in opioid users with a sweat patch J Anal Toxicol 1996
Reid LD, Hubbell CL, Tsai... Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... Pharmacol Biochem Be... 1996
Kauert G, Rohrich J Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacet... Int J Legal Med 1996
Matthias P, Tashkin DP, M... Effects of varying marijuana potency on deposition of tar and delta9-T... Pharmacol Biochem Be... 1997
Moeller MR, Steinmeyer S,... Determination of drugs of abuse in blood J Chromatogr B Biome... 1998
Lane JD, Kasian SJ, Owens... Binaural auditory beats affect vigilance performance and mood Physiol Behav 1998
Donnelly-Roberts DL, Putt... ABT-594 [R-5-2-azetidinylmethoxy-2-chloropyridine]: a novel, orally ef... J Pharmacol Exp Ther 1998
Thongpradichote S, Matsum... Identification of opioid receptor subtypes in antinociceptive actions ... Life Sci 1998
Smith FL, Cichewicz D, Ma... The enhancement of morphine antinociception in mice by delta9-tetrahyd... Pharmacol Biochem Be... 1998
Gessa GL, Casu MA, Carta ... Cannabinoids decrease acetylcholine release in the medial-prefrontal c... Eur J Pharmacol 1998
Gessa GL, Casu MA, Carta ... Cannabinoids decrease acetylcholine release in the medial-prefrontal c... Eur J Pharmacol 1998
Dafters RI, Duffy F, O'Do... Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in... Psychopharmacology (... 1999
Kramer E, Kovar KA On-line coupling of automated solid-phase extraction with high-perform... J Chromatogr B Biome... 1999
Erdtmann-Vourliotis M, Ma... Acute injection of drugs with low addictive potential (delta(9)-tetrah... Brain Res Mol Brain ... 1999
Yamamoto LT, Horie S, Tak... Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl... Gen Pharmacol 1999
van Aerts LAGJM, Malleret... N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties ... Addiction Biology 2000
Louw DF, Yang FW, Sutherl... The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in ra... Brain Res 2000
Galve-Roperh I, Saˇnchez ... Anti-tumoral action of cannabinoids: involvement of sustained ceramide... Nat Med 2000
Erdtmann-Vourliotis M, Ma... Prior experience of morphine application alters the c-fos response to ... Brain Res Mol Brain ... 2000
Uhl M Tandem mass spectrometry: a helpful tool in hair analysis for the fore... Forensic Sci Int 2000
Takayama H, Aimi N, Sakai... Chemical studies on the analgesic indole alkaloids from the traditiona... Yakugaku Zasshi 2000
Roth MD, Marques-Magallan... Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 ... Am J Respir Cell Mol... 2001
van der Stelt M, Veldhuis... Neuroprotection by Delta9-tetrahydrocannabinol, the main active compou... J Neurosci 2001
Takayama H, Ishikawa H, K... Studies on the synthesis and opioid agonistic activities of mitragynin... J Med Chem 2002

Page 1 of 2   /   152 Entries Returned
Pages:     
 1 
2 next